Dry Powder Inhaler Compositions Comprising Long Acting Muscorinic Antagonists

Patent No. EP2682099 (titled "Dry Powder Inhaler Compositions Comprising Long Acting Muscorinic Antagonists") was filed by Arven Ilac Sanayi VE Ticaret on Jul 4, 2013. The application was issued on Sep 2, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2682099

ARVEN ILAC SANAYI VE TICARET
Application Number
EP13175125A
Filing Date
Jul 4, 2013
Status
Revoked
May 9, 2025
Publication Date
Sep 2, 2020